UroGen Pharma
URGN
#6089
Rank
$0.47 B
Marketcap
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)

UroGen Pharma (URGN) - Cash on Hand

Cash on Hand as of December 2023 : $0.13 B

According to UroGen Pharma's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

UroGen Pharma - Cash on Hand chart (from 2016 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.13 B37.02%
2022-12-31$99.96 M12.14%
2021-12-31$89.13 M-12.62%
2020-12-31$0.10 B-30.64%
2019-12-31$0.14 B45.16%
2018-12-31$0.10 B38.79%
2017-12-31$73 M241.73%
2016-12-31$21.36 M18.84%
2015-12-31$17.97 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.20 B 52.00%๐Ÿ‡บ๐Ÿ‡ธ USA